同型半胱氨酸与缺血性心脑血管病关系的研究进展

[1] Homocysteine, fibrinogen, and lipoprotein（a） levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin[J] . Marek Naruszewicz,Malgorzata Klinke,Krzysztof Dziewanowski,Anna Staniewicz,Hanna Bukowska.Metabolism . 2001 (2)

[2] Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment[J] . G. H. J. Boers.European Journal of Pediatrics . 1998 (2)

[3] Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans [J]. CIRCULATION, 1997, 96 (08) : 2542 - 2544

[1] Homocysteine, fibrinogen, and lipoprotein（a） levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin[J] . Marek Naruszewicz,Malgorzata Klinke,Krzysztof Dziewanowski,Anna Staniewicz,Hanna Bukowska.Metabolism . 2001 (2)

[2] Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment[J] . G. H. J. Boers.European Journal of Pediatrics . 1998 (2)

[3] Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans [J]. CIRCULATION, 1997, 96 (08) : 2542 - 2544